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Abstract
p38 MAP kinase is known to be activated by cellular stress finally leading to cell cycle arrest or apoptosis.
Furthermore, a tumour suppressor role of p38 MAPK has been proposed. In contrast, a requirement of p38 for
proliferation has also been described. To clarify this paradox, we investigated stress- and mitogen-induced p38
signalling in the same cell type using fibroblasts. We demonstrate that - in the same cell line - p38 is activated by
mitogens or cellular stress, but p38-dependent signalling is different. Exposure to cellular stress, such as anisomycin,
leads to a strong and persistent p38 activation independent of GTPases. As a result, MK2 and downstream the
transcription factor CREB are phosphorylated. In contrast, mitogenic stimulation results in a weaker and transient
p38 activation, which upstream involves small GTPases and is required for cyclin D1 induction. Consequently, the
retinoblastoma protein is phosphorylated and allows G1/S transition. Our data suggest a dual role of p38 and
indicate that the level and/or duration of p38 activation determines the cellular response, i.e either proliferation or
cell cycle arrest.
Keywords: p38 MAPK, Signalling, Cellular stress, Mitogens, Fibroblasts
Background
The family of mitogen-activated protein kinases (MAPKs)
involves ERKs (extracellular signal-regulated kinases),
JNKs (c-Jun-N-terminal kinases) and p38 MAPKs. They
are proline-directed Ser/Thr kinases mediating a variety of
cellular responses due to numerous extracellular stimuli.
While the ERK pathway is preferentially induced by mito-
gens, p38 and JNK are generally activated by inflammatory
cytokines and cellular stress, such as hyperosmolarity, heat
shock, genotoxic compounds, UV light, g-irradiation,
metabolic stress, and protein synthesis inhibition [for
review see [1-4]]. Mammalian p38 was first cloned by Han
and coworkers and revealed close homology to the yeast
osmosensing HOG1 [5]. A common response of p38 acti-
vation by cellular stress is cell cycle arrest or apoptosis.
Moreover and consistent with its role in cell cycle regula-
tion, p38 is involved in oncogene-induced senescence,
replicative senescence, differentiation, and DNA-damage
response [for review see [6]]. For instance, several reports
indicate an inhibitory role of p38 in proliferation in the
mouse fibroblast cell line NIH3T3. Tunicamycin-treat-
ment causes activation of p38 resulting in phosphorylation
of GADD153 finally leading to cell cycle block [7]. G1-
arrest is also detected in response to arsenite, which is
mediated by a p38-dependent increase in p21 [8]. Consti-
tutive expression of oncogenic ras results in sustained acti-
vation of p38 and inhibition of proliferation [9]. Consistent
with a negative role in cell cycle progression, expression of
active MKK3/6 induces G1 arrest in the same cell line
[10]. Similar data has been obtained in rhabdomyosarcoma
cells, in which p38 activation results in G1-arrest and dif-
ferentiation [11]. We recently revealed that sustained acti-
vation of p38 in response to high cell density is involved in
the signalling cascade of contact-inhibition in murine and
in human FH109 fibroblasts by regulating levels of the
Cdk-inhibitor p27 [12].
However, several reports suggest that p38 is also acti-
vated in mitogenic pathways. Maher described a
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PDGF-stimulated) cell proliferation in Swiss3T3 fibro-
blasts [13]. A similar role has been proposed in hepato-
cytes after EGF- and insulin-treatment [14], and ERK
cooperates with p38 in G-CSF-stimulated hematopoietic
cell proliferation [15]. A proliferative role of p38 has
also been described in breast cancer-, chondrosarcoma-,
and melanoma cells [16-18]. These reports suggest a
proliferative function of p38 in contrast to the above
mentioned role of p38 in stress response and cell cycle
arrest.
Some simple explanations for these discrepancies
could be dependence on stimulus, cellular context or
cell-type specificity. For example, p38 activation by one
type of stimulus might lead to different biological out-
comes, i.e. proliferation or growth arrest, dependent on
cell type. Alternatively, distinct stimuli could induce p38
signalling via different routes in the very same cell type
thus triggering diverging responses. Unfortunately, the
proliferative and growth inhibitory role of p38 has been
investigated so far only in different cell lines and thus
the possibility of divergent p38 signalling downstream of
different stimuli in simply the same cell line is poorly
understood. Therefore we studied p38 signalling in
human and murine fibroblast cell lines and compared
the signalling cascades up- and downstream of p38 in
response to mitogens and cellular stress. Here we show
that mitogen-induced proliferation in NIH3T3 and
FH109 fibroblasts can be substantially blocked by the
compound SB203580, which is a selective inhibitor of
p38 [19] again demonstrating that p38 mediates cellular
proliferation. Since p38 also regulates cell cycle arrest in
the same cell lines as mentioned above, we analysed
mitogen- and stress-induced activation of p38 in
NIH3T3 and FH109 fibroblasts. We provide evidence
for a dual role of p38 in cell cycle control and suggest
that the level and/or the duration of p38 activation
might determine the cell’s decision to proliferate or to
induce cell cycle arrest. We show that in NIH3T3 and
FH109 fibroblast cell lines mitogenic stimuli lead to a
weak and transient phosphorylation of p38, which is
absolutely required for G1/S-transition whereas aniso-
mycin induces a strong and sustained activation of p38.
We further revealed that the signalling cascades invol-
ving p38 activation after serum- and stress-treatment
differ. While mitogenic activation of p38 upstream
involves small GTPases and downstream leads to cyclin
D1 expression, anisomycin-dependent activation of p38
is independent of GTPases and leads to phosphorylation
of MK2 and finally CREB. In conclusion, our data pro-
vide an example of differentially wired p38 signalling in
response to distinct stimuli, which results in specific
outputs such as stress-induced cell cycle arrest and
mitogen-induced proliferation.
Results
Involvement of p38 in mitogen-induced proliferation
Cellular stress is known to induce p38-dependent cell cycle
arrest in NIH3T3 cells as does constitutive activation of
p38 as mentioned above [7-10]. To investigate whether p38
is also involved in cell cycle progression, NIH3T3 were ren-
dered quiescent by serum-depletion and then stimulated
with fetal calf serum (FCS), platelet-derived growth factor-b
(PDGFb) or basic fibroblast growth factor (bFGF) in the
absence or presence of the p38-specific inhibitor SB203580
[19] or after p38a-knock-down via transient transfection of
siRNA targeted against murine p38a.p 3 8 a is the dominant
isoform in NIH3T3 and FH109 fibroblasts [[20], and own
unpublished observations]. As expected, stimulation with
FCS or the growth factors resulted in a marked increase in
DNA-synthesis as determined by [
3H]thymidine incorpora-
tion. This increase was substantially blocked by SB203580,
which was added one hour before the mitogens and was
then present throughout the entire experiment, or after
p38a knock-down (Figure 1A, B). Similar results were
obtained in the human fibroblast cell line FH109 (Addi-
tional file 1). As stated below using the transcription factor
CREB as a substrate, we demonstrated that SB203580 was
indeed active for at least 24 h as a p38 inhibitor. Further-
more, we confirmed, that siRNA-mediated knock-down of
p38a decreases growth factor-induced p38 phosphoryla-
tion. Importantly, phosphorylation of ERK1/2 was not
affected up to 4 h (Additional file 2A, B). In line with the
knock-down experiments, also the p38-inhibitor SB203580
did not alter mitogen-induced ERK1/2 phosphorylation at
early time points, but decreased ERK1/2 phosphorylation at
later time points (Additional file 2C). These data indicate
that SB203580 does not directly inhibit ERK1/2 function,
but that p38 activity seems to be required for sustained
ERK1/2 phosphorylation. Although SB203580 is considered
to be a highly specific inhibitor of p38 [19], inhibition of
JNK2 has been described [21]. Here, phosphorylation of the
JNK substrate c-Jun in response to anisomycin, a well-
known activator of JNK, is not inhibited by SB203580, but
as expected by the JNK-inhibitor SP600125 (Additional file
2D). Taken together, the previous experiments show that
p38 is activated after mitogenic stimuli and is required for
growth factor-induced re-entry of quiescent fibroblasts into
the cell cycle.
To investigate whether p38 is also required for continu-
ous proliferation, cells were seeded and cultured in 10%
FCS up to 72 h in the absence or presence of SB203580.
Figure 1C clearly shows that continuous proliferation of
NIH3T3 cells is impaired in the presence of SB203580.
Activation of p38 after mitogenic stimuli and cellular stress
p38 needs to be activated by dual phosphorylation on
threonine (180) and tyrosine (182) by MKK3 or MKK6
[22]. We therefore made use of a phospho-specific anti-
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Page 2 of 13p38-antibody (T180/Y182) and performed Western blot
analysis to compare p38 kinase activation in response to
mitogens and cellular stress. Indeed, time course analy-
sis revealed that p38 was clearly, but transiently
phosphorylated after FCS- and bFGF-stimulation in
serum-starved NIH3T3 cells (Figure 2A). In contrast,
treatment with the cellular stressors and known indu-
cers of p38 anisomycin or sorbitol [for review see [23]],
results in a stronger and persistent phosphorylation of
p38 (Figure 2B). Similar results were obtained in FH109
fibroblasts (Additional file 3).
Cell cycle proteins are differentially affected by p38
signalling after mitogenic stimuli or cellular stress
We next investigated cell cycle proteins as potential p38
downstream targets by Western blot analysis. A key regu-
lator of G1/S-transition is the retinoblastoma protein
(pRB). When phosphorylated, pRB dissociates from the
transcription factor E2F thereby allowing transcription of
S-phase specific genes, such as cyclin A, and subsequently
e n t r yi n t oS - p h a s e[ 2 4 ] .U s i ng a phospho-specific anti-
pRB-antibody we detected - as expected - phosphorylation
of pRB after stimulation with FCS which reached maximal
levels after 14 h and persisted thereafter (Figure 3A). Phos-
phorylation of pRB was also observed by a shift in the
electrophoretic mobility of pRB. Importantly, preincuba-
tion with SB203580 prevents pRB phosphorylation (Figure
3B) indicating that p38 is required for S-phase entry. Con-
sistent with the inhibition of pRB phosphorylation, main-
tained serum-induced expression of cyclin A was also
abolished in the presence of SB203580 (Figure 3C).
Phosphorylation of pRB is mediated by cyclin-dependent
kinases which are regulated by cyclins, namely by the
Cdk4/cyclin D1 complex and the Cdk2/cyclin E complex.
Hence, downregulation of cyclin D1 will lead to impaired
phosphorylation of pRB. Indeed, serum-induced expres-
sion of cyclin D1 is strongly attenuated in the presence of
SB203580 (Figure 3C). Downregulation of cyclin D1
expression by SB203580 was still detected 24 h after mito-
genic stimulation (Additional file 4A). Thus, inhibition of
p38 does not merely delay cyclin D1 expression, but pre-
vents cyclin D1 induction. Similar findings were obtained
in FH109 cells (Additional file 4B).
In contrast, anisomycin and sorbitol treatment led to a
complete loss of cyclin D1 expression. However, this effect
could not be reversed by SB203580 (Figure 3D). Hence,
downregulation of cyclin D1 in response to cellular stress
is probably mediated in addition by other stress kinases or
pathways in NIH3T3 cells.
Transcription factors are differentially targeted by p38
after mitogenic stimuli or cellular stress
We next focussed our interest on known transcription fac-
tors. In co-transfection and in vitro experiments, the tran-
scription factors activating transcription factor-2 (ATF-2)
and cAMP-responsive element-binding protein (CREB)
have been described to be excellent p38 substrates [25-27].
We therefore performed Western blot analysis with
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Figure 1 Effect of impairment of p38 function on mitogen-
induced DNA-synthesis. (A) Serum-starved NIH3T3 cells were either
not pretreated or preincubated for 1 h with SB203580 (10 μM). The
cells were then stimulated with 10% FCS, PDGFb or bFGF (each 50
ng/ml) for 20 h and labelled with [
3H]thymidine for additional 4 h in
the absence or presence of SB203580. Incorporated radioactivity was
determined by liquid scintillation spectrometry. Results are given as
x-fold induction of [
3H]thymidine incorporation compared to
unstimulated, serum-starved cells and are the average ± Sx of a
number of four for each run of treatment. The results represent one
out of three independent experiments each leading to similar results.
(B) NIH3T3 cells were transiently transfected with siRNA directed
against p38a or with control siRNA. Knock-down is shown by
Western blot analysis. Cells were serum-starved and then stimulated
with bFGF or PDGFb. DNA-synthesis was determined as described in
(A). (C) 0.06 × 10
6 NIH3T3 cells were seeded in 4.5 cm
2 dishes. Cells
were either not treated or treated with SB203580 (10 μM) 4 h after
seeding and then cultured in the absence or presence of SB203580
for another 68 h. Cells were counted in a hemocytometer. The results
are expressed as the average ± Sx of a number of four for each time
point and treatment. The results represent one out of two
independent experiments.
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nizing ATF-1) antibodies after FCS- and anisomycin-expo-
sure in the absence or presence of SB203580. To our
surprise, ATF-2 phosphorylation was not inhibited by
SB203580 neither after FCS- nor after anisomycin-treat-
ment (Figure 4A). In contrast, phosphorylation of ATF-2
was strongly blocked by the JNK-inhibitor SP600125. Co-
treatment of cells with both inhibitors of JNK and p38 did
not further reduce ATF-2 phosphorylation demonstrating
that JNK is the responsible kinase for ATF-2 phosphoryla-
tion in response to anisomycin (Figure 4B). These results
argue against a requirement for p38 in ATF-2 phosphory-
lation in fibroblasts. Interestingly, also CREB phosphoryla-
tion in response to FCS-stimulation was not affected by
SB203580 ruling out an involvement of p38 (Figure 4C).
In contrast, anisomycin-induced phosphorylation of
CREB/ATF-1 was totally abolished in the presence of
SB203580 even after 24 h (Figure 4C) indicating that p38
is the only kinase mediating CREB phosphorylation under
these conditions. Similar results were obtained in FH109
cells (Additional file 5). Consistent with these data, phos-
phorylation of MK2, which is known to mediate p38-
dependent CREB phosphorylation [27,28], was only
detectable after anisomycin-treatment, but not after FCS-
stimulation, neither after prolonged treatment (Figure 4D),
nor when analysing very early time points (Figure 4E).
Anisomycin-induced CREB phosphorylation is mediated
by the p38-MK2 pathway, as phosphorylation of MK2 in
response to anisomycin was totally abolished in the pre-
sence of SB203580.
FCS-, but not anisomycin-induced phosphorylation of p38
is dependent on GTPases
We next investigated the involvement of small GTPases,
comprising Ras, Rap and the family of Rho proteins (Rac,
Rho and Cdc42) in p38 activation. Cells were preincu-
bated with bacterial toxins to inhibit GTPase activity [for
review see [29-31]]. Effective concentrations of the bac-
terial toxins were prior titrated by visualising changes in
the integrity of the cytoskeleton via FITC-phalloidin
staining (see addional file 6A). After preincubation with
the toxins, cells were stimulated with FCS or anisomycin
for 30 min and Western blot analysis was then performed
with the phospho-specific anti-p38-antibody. Figure 5A
clearly demonstrates that pretreatment with Lethal Toxin
(LT) and Toxin B (TB), but not with C2IN-C3 toxin (C3)
totally abolished serum-stimulated p38 phosphorylation.
This indicates that FCS-dependent phosphorylation of
p38 is dependent on small GTPases, but probably inde-
pendent of Rho itself. None of the toxins (LT, TB, C3)
was able to block anisomycin-induced p38 phosphoryla-
tion (Figure 5B). The specificity of the toxins was further
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Figure 2 Stimulation of p38 by mitogens and cellular stress. (A, B) Serum-starved NIH3T3 cells were treated with FCS or bFGF (A),
anisomycin (10 &#956g/ml) or sorbitol (400 mM) (B) and total cell extracts prepared at the indicated time points. Western blot analysis was
performed using a phospho-specific (T180/Y182) anti-p38-antibody. The blots were stripped and reprobed with an anti-p38-antibody to control
equal loading. Data from a single experiment are shown. Similar results were obtained in three independent experiments.
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Figure 3 Analysis of cell cycle proteins as potential p38 downstream targets. (A) Serum-starved NIH3T3 cells were stimulated with FCS or
(B) stimulated with FCS in the absence or presence of SB203580 for the indicated time points. Western blot analysis was performed using a
phospho-specific (S807/S811) anti-pRB-antibody. The blots were stripped and reprobed with anti-gelsolin-antibody to control equal loading. The
same samples were loaded and subjected to Western blot analysis using a pRB-antibody. RB* = phosphorylated pRB. (C) Serum-starved NIH3T3
cells were not pretreated or pretreated with SB203580 and then stimulated with FCS for the indicated time points. Western blot analysis was
performed using anti-cyclin D1- (left) or anti-cyclin A-antibodies (right). (D) Serum-starved NIH3T3 cells were exposed to anisomycin or sorbitol
for the indicated time points (left) or exposed to sorbitol for 6 h after preincubation with SB203580 (right). Western blot analysis was performed
using anti-cyclin D1-antibody. Equal loading was controlled by stripping and reprobing the blots with anti-ERK2-antibody.
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Figure 4 Analysis of p38-mediated substrate phosphorylation. (A) Serum-starved NIH3T3 cells were either not pretreated or pretreated with
SB203580. Cells were not stimulated, stimulated with FCS (left) or with anisomycin (right) for 15 min. Total cell extracts were performed and subjected
to Western blot analysis. Phosphorylation of ATF-2 was detected using a phospho-specific antibody, equal loading was controlled by stripping and
reprobing the blot with anti-ATF-2-antibody. (B) NIH3T3 cells were either not treated or treated with anisomycin in the absence or presence of
SB203580 (10 &#956M), SP600125 (25 &#956M) or both inhibitors for 15 min. Western blot analysis was performed as described above. (C) Serum-
starved NIH3T3 cells were either not pretreated or pretreated with SB203580 and then stimulated with FCS (left) or anisomycin (right) for the indicated
time points. Total cell extracts were performed and subjected to Western blot analysis. Phosphorylation of CREB was detected using a phospho-
specific antibody, equal loading was controlled by stripping and reprobing the blot with anti-CREB-antibody. The anti-phospho-CREB-antibody also
recognizes phosphorylated ATF-1. ATF-2* = phosphorylated ATF-2. (D) Serum-starved NIH3T3 cells were either not treated or treated with FCS or
anisomycin for the indicated time points. Western blot analysis was performed using a phospho-specific anti-MK2-antibody. The blot was stripped and
reprobed with anti-PCNA-antibody to control equal loading. (E) Serum-starved NIH3T3 cells were either not treated or treated with FCS or anisomycin
for the indicated time points in the absence or presence of SB203580 (10 &#956M). Western blot analysis was performed using a phospho-specific
anti-MK2-antibody. The blot was stripped and reprobed with anti-PCNA-antibody to control equal loading.
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response to FCS, which is downstream of Ras but not the
other GTPases, was only blocked by LT but not by TB and
C3 (Additional file 6B) [32]. The same was demonstrated
in FH109 cells (data not shown). In conclusion, our results
strongly argue for an involvement of GTPases in FCS-, but
not in anisomycin-induced p38 phosphorylation.
In summary, we propose a hypothetical model for p38
signalling downstream of distinct stimuli which is
depicted in Figure 6. We propose that discrete mechan-
isms lead to p38 activation after FCS- and anisomycin-
exposure. Mitogens, but not cellular stress mediated by
anisomycin, operate via small GTPases and subsequently
trigger p38-dependent regulation of the retinoblastoma
pathway. However, stress-induced p38 signalling initiates
MK2 activity and hence phosphorylation of CREB with-
out a concomitant proliferative response.
Discussion
In the present work we show that p38 is activated by mito-
gens and cellular stress in the same cell line, but that the
signalling pathways differ. We suggest that p38 plays a
dual role in cell cycle control in fibroblasts mediating cell
cycle progression or cell cycle arrest depending on the
extracellular stimulus. In NIH3T3 cells, p38-dependent
cell cycle arrest either due to cellular stress or constitutive
activation by overexpression of the kinase itself or an
upstream activating kinase has been demonstrated in var-
ious publications [7-10]. The fact that in the present study
in the same cell line stimulation with serum or growth
C
Toxin Inhibition
Clostridium sordellii Lethal Toxin (LT) Ras, Rac, Rap
Clostridium difficile  Toxin B (TB) Rac, Cdc42, Rho
Clostridium botulinum  C3 exoenzyme (C3) Rho
-
anisomycin - +++
TB LT
A
--++ toxin
p-p38(T180/Y182)
p38
B
p-p38(T180/Y182)
p38
FCS + +++
toxin - + - ++
TB C3 LT
Figure 5 Effect of inhibiting small GTPases by bacterial toxins on p38 phosphorylation. (A, B) Serum-starved NIH3T3 cells were either not
pretreated or preincubated for 23 h with 400 ng/ml of C2IN-C3 (C3), for 2 h with 200 ng/ml of Lethal Toxin (LT), or for 2.5 h with 10 ng/ml of
Toxin B (TB). Cells were either not stimulated or stimulated for 30 min with FCS (A) or anisomycin (B). Western blot analysis was performed with
a phospho-specific anti-p38-antibody followed by reprobing with anti-p38-antibody. (C) Presentation of the bacterial toxins used indicating their
substrate specificity according to [29-31].
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and - vice versa - FCS- and growth factor-induced DNA-
synthesis is blocked by the p38-specific inhibitor
SB203580 or siRNA-mediated knock-down of p38 clearly
indicates that p38 is also required for proliferation and
points to a dual role of p38 in cell cycle regulation. Our
data suggest that a key element might be the duration
and/or amount of activation which then leads to different
downstream signalling. While anisomycin-exposure leads
to a strong and sustained activation of the p38 and MK2
kinases, thereby increasing the phosphorylation of CREB
[27,28], mitogen-induced activation of p38 is weaker and
transient, but is required for cyclin D1 expression. In addi-
tion, we demonstrate that p38 is differentially regulated in
response to anisomycin and mitogens with respect to the
involvement of small GTPases (Figure 6).
Dual regulation of a kinase depending on the extracellu-
lar stimulus has been proposed in the neuronal cell line
PC12 for ERK [for review see [33]]. In these cells, EGF
leads to a transient activation of ERK with cytoplasmic
retention resulting in a proliferative cellular response. In
contrast, NGF-induced ERK activation in the same cells is
sustained and accompanied by a nuclear translocation
causing cell cycle arrest and neuronal differentiation.
To better understand the role of p38 in mitogen-
induced proliferation, we studied cell cycle proteins, i.e.
phosphorylation of pRB and expression of the cyclins D1
and A. It is generally accepted that during G1-phase,
cyclin D1/Cdk4 and downstream cyclin E/Cdk2 phos-
phorylate pRB which then dissociates from the transcrip-
tion factor E2F allowing transcription of S-phase specific
genes, such as cyclin A, and thereby entry into S-phase
[24]. Since the mitogen-induced expression of cyclin D1
was strongly reduced in the presence of SB203580 we
conclude that expression of cyclin D1 requires the activ-
ity of p38. An expected consequence of a decrease in
cyclin D1 is less activity of the cyclin D1/Cdk4 complex
and in turn less phosphorylation of pRB. Hence, the
observed attenuation of pRB phosphorylation in the pre-
sence of SB203580 is very likely due to decreased cyclin
D1 expression. Downregulation of cyclin A by SB203580
was observed at a later time point, i.e. 14 h after mito-
genic stimulation. According to the kinetics of pRB phos-
phorylation we assume that this time point correlates
with early S-phase. We therefore conclude that the
decrease in cyclin A is not directly mediated by p38, but
rather a consequence of inhibition of pRB phosphoryla-
tion by SB203580.
The mechanism of p38-dependent expression of cyclin
D1 in our cell system is not known so far. In melanoma
cells, p38-ATF-2-dependent expression of cyclin D1 in
response to hepatocyte growth factor/scatter factor has
been described [18]. Induction of cyclin D1 by pp60
v-src
is also mediated via the p38/JNK-ATF-2/CREB pathway
weaker and transient
p38 activation
Mitogenic stimulation
(serum)
Cellular stress
(anisomycin)
strong and persistent
p38 activation
pRB
cyclin D1
CREB
proliferation cell cycle arrest
GTPases not involved GTPases involved 
MK-2
Figure 6 Proposed hypothetical model describing different p38 signalling pathways in response to mitogens and cellular stress.
Anisomycin leads to a sustained phosphorylation of p38 which is independent of upstream-acting small GTPases and accompanied by an
accumulation of p38 in the nucleus. One downstream substrate of p38 is CREB. In contrast, p38 is transiently phosphorylated after serum-
stimulation in a GTPase-dependent manner and cyclin D1 is upregulated. The cellular response is proliferation.
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Page 8 of 13in human breast cancer cells [34]. Since we did not detect
p38-dependent phosphorylation of ATF-2 nor CREB, an
involvement of ATF-2 or CREB in cyclin D1 expression
in our cell system is unlikely. One possible explanation
comes from the observation, that ERK1/2 phosphoryla-
tion is blocked from 6 h on after FCS-stimulation, very
likely as a secondary effect of p38 inhibition. Hence, p38
activity seems to be required for sustained ERK1/2 phos-
phorylation. In fibroblasts, sustained ERK1/2 activity is
required for cyclin D1 expression, especially during mid-
G1-phase [35]. The underlying mechanism of this cross-
talk between p38 and ERK1/2 remains to be elucidated.
To our surprise, inhibition of p38 function by
SB203580 did not only block mitogen-induced G0/G1-S
transition, but also attenuated continuous proliferation
of NIH3T3 cells. This observation is in contrast to data
obtained in BJ primary fibroblasts and WI-38 fibroblasts.
In these cells, SB203580 does not alter proliferation in
exponentially growing cultures, which show doubling
rates comparable to our NIH3T3 [36,37]. However, cell
type specific differences might explain different func-
tions of p38 in NIH3T3 cells. Very recently, it was
shown that the transcription factor FoxM1 acts down-
stream from the Ras-MKK3-p38 pathway in NIH3T3
cells [38]. Importantly, FoxM1 is also known to regulate
a number of proliferative genes [38; manuscript in pre-
paration]. Although we have not tested, another expla-
nation for the discrepancies could be p53 function.
While BJ and WI-38 fibroblast express wild-type p53
[39,40], the NIH3T3 cells we used are p53-deficient
(unpublished observations).
Our observation of a sustained p38 activation after ani-
somycin- or sorbitol-treatment is in accordance with other
reports showing persistent activation of p38 after cellular
stress, e.g. in C3H10T1/2 cells in response to anisomycin
or UV [41] or in several cell lines in response to g-irradia-
tion, genotoxic compounds or during premature senes-
cence [[42,43], reviewed in [6]].
We have also shown that sustained activation of p38 is
required for contact-inhibition in murine and human
fibroblasts [12]. Several mechanisms explaining p38-
dependent cell cycle arrest have been described. For
instance, p27
KIP1, a well-known inhibitor of Cdk2 and
Cdk4, is one important downstream target of p38 upon
contact-inhibition [12,44]. The protein p27
KIP1 is also
upregulated in response to genotoxic agents and here is
supposed to be crucial for maintenance of cell cycle arrest
[43]. However, we did not observe accumulation of
p27
KIP1 in response to anisomycin or sorbitol (unpub-
lished oberservation). It is also known that the Cdk inhibi-
tors p21
WAF1/CIP1 and p16
INK4a mediate p38-dependent
senescence, for instance in response to DNA-damaging
agents and reactive oxygen species, which might be related
to the role of p38 as a tumour suppressor [42,45-51]. Very
recently, p38-dependent induction of p21 due to sorbitol-
treatment has been described in nucleus pulposus inter-
vertebral disc cells [52]. Whether p21
WAF1/CIP1 or
p16
INK4a are upregulated in response to anisomycin or
sorbitol in fibroblasts needs to be determined.
Moreover, we observed sustained phosphorylation of
CREB. Two kinases are known to phosphorylate this tran-
scription factor: MK2 [27,28] and MSK1 [26]. Since MK2
was also persistently activated in response to anisomycin,
we conclude that MK2 at least partially contributes to
phosphorylation of CREB. A possible involvement of
MSK1 remains to be elucidated. Interestingly, cell cycle
arrest due to sustained activation of the cAMP/CREB-
pathway was also detected in prostate carcinoma cells,
which were chronically exposed to pituitary adenylate-
cyclase-activating polypeptide. In contrast, transient stimu-
lation of cAMP/CREB induces proliferation [53]. Constitu-
tive activation of CREB by bacterial toxins leads to
G1-arrest in a murine macrophage cell line by induction
of p27 and downregulation of cyclin D1 [54]. In accor-
dance, cholera toxin, a potent inducer of cellular accumu-
lation of cAMP and thereby phosphorylation of CREB, is
able to cause G1 arrest by upregulation of p27, p21 and
downregulation of cyclin D1 in rat and primary human
glioma cells [55]. However, we could not reverse downre-
gulation of cyclin D1 in response to sorbitol-exposure by
SB203580 arguing that p38 is not the sole entity responsi-
ble for the decrease in cyclin D1. This is in line with the
observation that arsenite-induced downregulation of cyclin
D1 in NIH3T3 cells cannot be restored by SB203580 [8]
and that cyclin D1 decrease can also be mediated by JNK
[56]. Hence, the precise function of the p38-MK2-CREB
axis in anisomycin- or sorbitol-induced cell cycle arrest
remains to be determined.
Phosphorylation of CREB in response to mitogenic sti-
mulation could not be blocked by SB203580, which is in
line with previous observations that CREB phosphoryla-
tion in response to growth factors is mediated by the
ERK pathway [26].
Interestingly, phosphorylation of ATF-2 was not inhib-
ited by SB203580, although it has been identified to be an
excellent substrate for p38 in vitro [25]. This observation
is in perfect accordance with the work of Hazzalin and
coworkers [41] and the work by Maher [13] ruling out
involvement of p38 in phosphorylating endogenous ATF-2
in fibroblasts. Since phosphorylation of ATF-2 could be
blocked by pharmacological inhibition of JNK, phosphory-
lation of ATF-2 is very likely dependent on JNK [57].
Persistent activation after anisomycin is consistent with
the supposed mechanism of action: anisomycin inhibits
protein synthesis hence blocking transcription of phos-
phatases. As a result, p38 dephosphorylation does not
occur in the presence of anisomycin. Furthermore,
dephosphorylation of the upstream acting MKK3/6 is
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similar mechanism has been described for arsenite-
induced JNK activation [58,59]. To gain more insight
into upstream events regulating p38 activity in response
to mitogens, we identified the involvement of small
GTPases and made use of selective bacterial toxins. Clos-
tridium sordellii Lethal Toxin (LT) inhibits Ras, Rac, and
Rap function, Clostridium difficile Toxin B abolishes Rac,
Cdc42, and Rho function, and Botulinus C3 exoenzyme,
in our study used as C2IN-C3 fusion toxin displaying
high cell permeability [60], selectively inhibits Rho func-
tion [29,30]. The observation, that ERK activation was
selectively abolished only in the presence of Lethal Toxin
indicates selectivity of the toxins. In control experiments
with Botulinus C2 toxin, which ADP-ribosylates actin
[29], we ruled out that the observed inhibitory effects of
the toxins occurred unspecifically due to degradation of
the actin cytoskeleton (unpublished observation). If ani-
somycin-induced p38 activation is due to its suppression
of phosphatases (see above) it should be independent of
Rho proteins. Indeed, blocking the activity of the small
GTPases Rho, Rac, and Cdc42 by preincubation with
Lethal Toxin or Toxin B, had no effect on anisomycin-
induced p38 phosphorylation.
On the contrary, serum-induced p38 activation could be
blocked by preincubation with Toxin B and Lethal Toxin.
In view of the fact that C2IN-C3 had no effect on serum-
induced p38 phosphorylation, the results strongly argue
against an involvement of Rho and point to a potential
role of Rac and/or Ras and Cdc42. Indeed, in overexpres-
sion studies, Rac and Cdc42 have been identified to med-
iate p38 activation [10,61,62]. More detailed analysis is
required to identify which of the small GTPases is
involved in p38-mediated control of proliferation.
Conclusions
We present a novel hypothetical model for p38 function
and propose a dual role of p38 activation in cell cycle
control. Cellular stress by anisomycin leads to a sustained
phosphorylation and activation of p38. One downstream
substrate of p38 is MK2 which phosphorylates CREB. In
contrast, after mitogenic stimulation p38 is only transi-
ently phosphorylated, but promotes cyclin D1 expression.
The cellular response is proliferation. Differential target
activation by p38 downstream of mitogenic and stress
signals might be related to the respective strength or
duration of p38 activation or, alternatively, to additional
cross-talk with parallel pathways - an issue which war-
rants further investigations.
Materials and methods
Cell culture
FH109 human embryonal lung fibroblasts [63] and
NIH3T3 murine fibroblasts were routinely cultured in
Dulbecco’s Modified Eagle’sM e d i u m( D M E M )( P A A ) ,
supplemented with 10% fetal calf serum (FCS) (PAA), 4
mM glutamine, penicillin and streptomycin (each 100 U/
ml). For experiments, FH109 or NIH3T3 cells were cul-
tured in DMEM/0.2% FCS for 72 h and then treated with
anisomycin (10 μg/ml) (Sigma) or FCS to a final concen-
tration of 10% and harvested at different time points as
described in the figure legends. Cells were pretreated with
SB203580 (10 μΜ) (Calbiochem), or SP600125 (25 μM)
(Enzo Life Sciences), control cells were exposed to 0.1%
DMSO, the solvent used for the inhibitors.
Measurement of DNA-synthesis
FH109 or NIH3T3 cells were seeded into microtiter plates
at a density of 8 × 10
3/well or 5 × 10
3/well, respectively,
and cultured for 72 h in DMEM/0.2% FCS. Cells were sti-
mulated for 24 h by the addition of 10% FCS, PDGF- or
bFGF (each 50 ng/ml, Cell Signaling). SB203580 was
added 1 h before stimulation. DNA-synthesis was mea-
sured by [
3H]thymidine-incorporation as described [64].
Determination of cell number
Cells were washed, trypsinised and counted in a
hemocytometer.
Western blotting
Total cell extracts were prepared by lysing the cells in hot
Laemmli sample buffer and protein concentration was
determined according to [65]. Equal amounts of protein
(20 - 50 μg protein/lane) were separated by SDS-PAGE
(7.5 - 10%) and electroblotted overnight onto Immobilon
membrane (Millipore). The membranes were blocked for
1 h with 5% low-fat milk-powder or 5% bovine serum
albumin in TBS (50 mM Tris-HCl, pH 7.5, 150 mM NaCl)
containing 0.05% Tween 20 and then incubated either for
1.5 h at room temperature with anti-cyclin D1-, anti-cyclin
A- (1:1000, Santa Cruz), or overnight at 4°C with anti-
phospho-pRb- (1:1000, Cell Signaling), anti-phospho-p38-,
anti-CREB, anti-phospho-ATF-2-, anti-phospho-c-Jun-, or
anti-phospho-MK2-antibody (1:1000-2000, Cell Signaling)
followed by incubation with horseradish-peroxidase-con-
jugated secondary antibody and ECL-detection according
to the manufacturer’s instructions. The blots were stripped
and reprobed with anti-p38a-, anti-phospho-CREB-,
(1:1000, Cell Signaling), anti-ATF-2-, anti-PCNA-, anti-
ERK-, or anti-c-Jun-antibody (1:1000, Santa Cruz) or anti-
gelsolin-antibody (1:200, Santa Cruz) followed by
ECL-detection.
Transfection of siRNA
For transient transfection of p38a or control siRNA, 5 ×
10
3 cells/well (96 well plate) were seeded and cultured
for 24 h to reach 80-90% confluence. Transfection was
performed in a total volume of 120 μl containing 8
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to the manufacturer’s instructions. After 24 h, medium
was changed to DMEM/0.2% FCS and the cells cultured
for another 24 h. Cells were then exposed for 24 h to
PDGFb or bFGF (see above) and incorporation of [
3H]
thymidine was determined. p38a siRNA (directed
against murine p38a mRNA sequence [MGI:1346865]):
5’-GGAAUUCAAUGACGUGU AC-3’;c o n t r o ls i R N A
(directed against mRNA encoding the red fluorescence
protein DsRed from the coral Discosoma) has been pub-
lished previously [66].
Additional material
Additional file 1: Effect of impairment of p38 function on mitogen-
induced DNA synthesis. Serum-starved FH109 cells were either not
pretreated or preincubated for 1 h with SB203580 (10 μM). The cells
were then stimulated with 10% FCS, PDGFb, bFGF (each 50 ng/ml) or
EGF (100 ng/ml) for 20 h and labelled with [3H]thymidine for additional
4 h. Incorporated radioactivity was determined by liquid scintillation
spectrometry. Results are given as x-fold induction of [
3H]thymidine
incorporation compared to unstimulated, serum-starved cells and are the
average ± Sx of a number of four for each run of treatment. The results
represent one out of three independent experiments each leading to
similar results.
Additional file 2: Specificity of SB203580-treatment and siRNA-
mediated knock-down of p38. (A, B) NIH3T3 cells were transiently
transfected with siRNA directed against p38a or with control siRNA. 24 h
after transfection, cells were serum-starved and cultured for another 24 h.
Cells were then stimulated with PDGFb (50 ng/ml) (A) or bFGF (50 ng/
ml) (B) for the indicated time points. Western blot was performed using
a monoclonal phospho-specific anti-p38-antibody. In parallel, the same
samples were subjected to Western blot analysis using anti-p38-antibody.
The blot was stripped and incubated with a monoclonal anti-phospho-
ERK1/2-antibody. The blot was stripped again and subjected to
immunoblotting using an ERK2-antibody to control equal loading. (C)
Serum-starved NIH3T3 cells were treated with FCS in the absence or
presence of SB203580 (10 μM) for the indicated time points. Western
blot analysis was performed using anti-phospho-ERK1/2-antibody. Blots
were stripped and reprobed with anti-ERK2-antibody to control equal
loading. (D) NIH3T3 cells were not stimulated or stimulated with
anisomycin in the absence or presence of SB203580 (10 μM), SP600125
(25 μM) or both inhibitors for the indicated time points. Western blot
analysis was performed using a phospho-specific anti-c-Jun-antibody.
Blots were stripped and reprobed with anti-c-Jun-antibody to control
equal loading.
Additional file 3: Stimulation of p38 by mitogens and cellular stress.
Serum-starved FH109 cells were treated with FCS (A), or anisomycin (10
μg/ml) (B) and total cell extracts prepared at the indicated time points.
Western Blot analysis was performed using a phospho-specific (T180/
Y182) anti-p38-antibody. The blots were stripped and reprobed with an
anti-p38-antibody to control equal loading. Data from a single
experiment are shown. Similar results were obtained in three
independent experiments. (C) Serum-starved FH109 cells were untreated
or stimulated with FCS or anisomycin for 30 min. Kinase activity was
measured after immunoprecipitation with a monoclonal phospho-
specific anti-p38-antibody and ATF-2 fusion protein as substrate.
Phosphorylation of ATF-2 was determined by Western blot analysis with
a phospho-specific anti-ATF-2-antibody.
Additional file 4: Serum-starved NIH3T3 (A) or FH109 (B) cells were
not pretreated or pretreated with SB203580 and then stimulated
with FCS for the indicated time points. Western blot analysis was
performed using anti-cyclin D1- (A, B) or anti-cyclin A-antibodies (B).
Additional file 5: Analysis of p38 kinase mediated substrate
phosphorylation. Serum-starved FH109 cells were either not treated or
pretreated with SB203580. (A, B) Cells were not stimulated, or stimulated
either with FCS (A) or anisomycin (B) for 15 min. Total cell extracts were
performed and subjected to Western blot analysis. Phosphorylation of
CREB and ATF-2 was detected using phospho-specific antibodies, equal
loading was controlled by anti-CREB- and anti-ATF-2-antibodies. The anti-
phospho-CREB-antibody also recognizes phosphorylated ATF-1. ATF-2* =
phosphorylated ATF-2 (C) Serum-starved FH109 cells were either not
treated or stimulated with anisomycin and cell extracts prepared at the
indicated time points. Western blot analysis for detection of CREB
phosphorylation was performed as described above.
Additional file 6: Inhibition of small GTPases by bacterial toxins
characteristically deregulates actin cytoskeleton and ERK1/2-
phosphorylation. Serum-starved NIH3T3 cells were either not pretreated
or preincubated for 23 h with 400 ng/ml of C2IN-C3 (C3), for 2 h with
200 ng/ml of Lethal Toxin (LT), or for 2.5 h with 10 ng/ml of Toxin B (TB).
(A) FITC-phalloidin staining to visualise activity of the bacterial toxins. As
expected, exposure to C3 induces depolymerisation of actin stress fibres
with little effect on lamellipodia or filopodia, TB strongly depolymerises
the actin cytoskeleton [31], and LT causes rounding of cell bodies and
disruption of actin stress fibres [32]. (B) Cells were either not stimulated
or stimulated for 30 min with FCS. Western blot analysis was performed
with anti-ERK1/2-antibody. As already shown by [32], LT inhibits
phosphorylation of ERK1/2. ERK1*/ERK2* = phosphorylated ERK1/ERK2.
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